MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, NVAX had $14,375K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$14,375K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net income (loss)
-202,379 625,154
Depreciation and amortization
6,585 15,903
Impairment of long-lived assets
-349
Non-cash stock-based compensation
8,549 19,499
Provision for excess and obsolete inventory
566 1,379
Impairment of assets held for sale
97,038 -
Impairment of long-lived assets
3,382 -
Loss on debt extinguishment
-28,714 -
Other items, net
229 -4,682
Inventory
3,753 1,635
Accounts receivable, prepaid expenses, and other assets
-207,927 94,947
Accounts payable, accrued expenses, and other liabilities
-26,535 -274,488
Deferred revenue
-11,712 -608,860
Net cash provided by (used in) operating activities
107,804 -312,964
Capital expenditures
2,017 1,467
Purchases of available-for-sale marketable securities
235,012 114,724
Proceeds from maturities of available-for-sale marketable securities
100,500 154,625
Internal-use software
0 655
Net cash provided used in investing activities
-136,529 37,779
Net proceeds from sales of common stock
0 0
Proceeds on the issuance of convertible senior notes due 2031, net of issuance costs
42,606 -
Net proceeds from the exercise of stock-based awards
820 -5,288
Finance lease payments
984 2,813
Net cash provided by financing activities
42,442 -8,101
Effect of exchange rate on cash, cash equivalents, and restricted cash
658 6,976
Net increase (decrease) in cash, cash equivalents, and restricted cash
14,375 -276,310
Cash and cash equivalents at beginning of period
545,292 -
Cash and cash equivalents at end of period
283,357 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

NOVAVAX INC (NVAX)

NOVAVAX INC (NVAX)